T1	Participants 79 153	acute moderate to severe asthma in children between 5 and 15 years of age:
T2	Participants 315 347	acute moderate to severe asthma.
T3	Participants 489 677	Children aged 5-15 years (without prior use of montelukast) with acute moderate to severe asthma exacerbation, as defined using Modified Pulmonary Index Score (MPIS) > or =9, were enrolled
T4	Participants 1070 1158	17 children (60 in montelukast group and 57 in placebo group) were enrolled in the study
T5	Participants 1691 1736	children with acute moderate to severe asthma
